摘要
积累的DNA损伤和损伤DNA修复系统参与不同的神经退行性疾病的发病机制。当DNA损伤太广泛,DNA损伤反应途径触发了细胞衰老或凋亡。然而,DNA损伤增加的水平是否在神经退行性疾病中是神经退行性的事件的原因而不是结果还有待建立。在可能的DNA损伤、DNA双链断裂(双边带)是罕见的事,然而它们是最致命的形式的DNA损伤。在神经元中,双边带尤其有害,因为它们比增殖细胞的DNA修复能力更低。 在这里,我们提供双边带修复系统的描述和形容人类研究显示几种类型的DNA损伤的存在主要在三个神经退行性疾病,包括阿尔茨海默病(AD)、帕金森病(PD)和亨廷顿氏病(HD)。然后,我们分析双边带的作用缺乏积累和双边带修复系统的神经退化通过研究神经退行性疾病的动物模型来检查。
关键词: 阿尔茨海默氏症、DNA损伤、DNA修复、DNA双链断裂、亨廷顿氏舞蹈症、神经退行性疾病、帕金森病。
Current Alzheimer Research
Title:DNA Double Strand Breaks: A Common Theme in Neurodegenerative Diseases
Volume: 13 Issue: 11
Author(s): Daniela Merlo, Cristiana Mollinari, Mauro Racaniello, Enrico Garaci, Alessio Cardinale
Affiliation:
关键词: 阿尔茨海默氏症、DNA损伤、DNA修复、DNA双链断裂、亨廷顿氏舞蹈症、神经退行性疾病、帕金森病。
摘要: Accumulation of DNA damage and impairment of DNA repair systems are involved in the pathogenesis of different neurodegenerative diseases. Whenever DNA damage is too extensive, the DNA damage response pathway provides for triggering cellular senescence and/or apoptosis. However, whether the increased level of DNA damage in neurodegenerative disorders is a cause rather than the consequence of neurodegenerative events remains to be established. Among possible DNA lesions, DNA double strand breaks (DSBs) are rare events, nevertheless they are the most lethal form of DNA damage. In neurons, DSBs are particularly deleterious because of their reduced DNA repair capability as compared to proliferating cells.
Here, we provide a description of DSB repair systems and describe human studies showing the presence of several types of DNA lesions in three major neurodegenerative diseases including Alzheimer’s disease (AD), Parkinson’s disease (PD) and Huntington’s disease (HD). Then, we analyze the role of DSB accumulation and deficiency of DSB repair systems in neurodegeneration by examining studies on animal models of neurodegenerative diseases.
Export Options
About this article
Cite this article as:
Daniela Merlo, Cristiana Mollinari, Mauro Racaniello, Enrico Garaci, Alessio Cardinale , DNA Double Strand Breaks: A Common Theme in Neurodegenerative Diseases, Current Alzheimer Research 2016; 13 (11) . https://dx.doi.org/10.2174/1567205013666160401114915
DOI https://dx.doi.org/10.2174/1567205013666160401114915 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Relevance of Dopamine D2/Neurotensin NTS1 and NMDA/Neurotensin NTS1 Receptor Interaction in Psychiatric and Neurodegenerative Disorders
Current Medicinal Chemistry Selective Inhibitors of Histone Deacetylase 10 (HDAC-10)
Current Medicinal Chemistry Membrane Estrogen Receptors Acting in the Central Nervous System
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) MiR-134, Mediated by IRF1, Suppresses Tumorigenesis and Progression by Targeting VEGFA and MYCN in Osteosarcoma
Anti-Cancer Agents in Medicinal Chemistry Exploring the Mitochondrial Apoptotic Cell Death Landscape and Associated Components Serving as Molecular Targets, Primarily for Synthetic and Natural Drugs Targeting Oncology Therapeutics
Current Molecular Pharmacology Current Management of Fetal and Neonatal Renal Tumors
Current Pediatric Reviews Role of the Insulin Receptor Variant Forms in Human Metabolic Disorders
Current Genomics Synthesis and Biological Evaluation of Acridine/Acridone Analogs as Potential Anticancer Agents
Medicinal Chemistry Delineation of Current Development of Antimitotic Compounds Targeting Cytoskeletal Protein Tubulin and Microtubule in the Cancer Therapy
Current Chemical Biology Effect of Genetic Polymorphisms (SNPs) in CHRNA7 Gene on Response to Acetylcholinesterase Inhibitors (AChEI) in Patients with Alzheimer’s Disease
Current Drug Targets Phytochemicals Resveratrol and Sulforaphane as Potential Agents for Enhancing the Anti-Tumor Activities of Conventional Cancer Therapies
Current Pharmaceutical Biotechnology Current Trends in Virtual High Throughput Screening Using Ligand-Based and Structure-Based Methods
Combinatorial Chemistry & High Throughput Screening Hyperglycemia, Hypoglycemia and Dementia: Role of Mitochondria and Uncoupling Proteins
Current Molecular Medicine Functionalized Silver Nanoparticles for Sensing, Molecular Imaging and Therapeutic Applications
Current Nanomedicine Interlocked Systems in Nanomedicine
Current Topics in Medicinal Chemistry Recent Developments of Melatonin Related Antioxidant Compounds
Combinatorial Chemistry & High Throughput Screening The Use of Cytokines and Chemokines in the Cancer Immunotherapy
Recent Patents on Anti-Cancer Drug Discovery Apoptosis Induction by Erucylphosphohomocholine via the 18 kDa Mitochondrial Translocator Protein: Implications for Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Emerging Molecular Functions of MicroRNA-9: Cancer Pathology and Therapeutic Implications
Anti-Cancer Agents in Medicinal Chemistry Cyclotron Production of PET Radiometals in Liquid Targets: Aspects and Prospects
Current Radiopharmaceuticals